20 INTERPHEX 2015 www.pharmpro.com
INTERPHEX 2015 SHOW DAILY
Indeed, serialization requires the intervention of different
suppliers (IT, line system manufacturers, vision inspection, printing manufacturers, etc.). All these actors must work together
to achieve an accurate serialization of the products. Often the
management does not realize how many departments will be
involved, and impacted in this new process: IT, validation, logistics, quality control, etc.
INTERPHEX: What don't most people realize about you or
BENOIT MAHEUX (OPTEL): Most pharmaceutical companies do not realize the importance of selecting a trusted and reliable Track & Trace solution provider. With limited budgets, some
companies tend to go with a cheap solution provider. These providers usually do not have a strong internal process to manage
complex projects. A delay of a few days or weeks on a project
can have a huge impact on a company’s production and profits.
Optel Vision has strong, proven, project management processes geared to avoiding delays and impacts to the delivery of
our advanced solutions. Cheap providers may attract customers
to their lower costs. However, in the end, the customer realizes
what they have paid for, and gets stuck with low-quality equipment that is incomplete, non-flexible and often costly or impossible to modify and expand.
Successful serialization requires a perfect architecture, beginning with a complete dedicated solution embracing balanced
and dependable communication at all levels and incorporating
different elements and providers. Without a balanced approach,
errors will happen, delays will occur, and for sure, the U.S.
FDA will sanction non-compliant manufacturers. If you think a
non-functioning or incomplete serialization process can be painful, our industry can expect to see fines, sanctions, and other
business penalties leveled in historic proportion.
Serialization is not only about manufacturing quality, we
remain committed to helping our customers avoid expensive
recalls and to prevent counterfeit products from entering their
INTERPHEX: What are you looking forward to at INTERPHEX
BENOIT MAHEUX (OPTEL): As with any sales opportunity,
our team looks forward to educating the audience, giving them
clear, useful information, while teaching them the benefits of being prepared to meet the T&T challenges which lie ahead.
Serialization and Track & Trace are important topics. It has
been years now since pharmaceutical companies first became
aware of these terms, yet, most people still do not fully understand what it implies or the urgency needed to address this process as soon as possible.
There are very few reliable Track & Trace solution providers in
the world. The closer we all get to the compliance deadlines, the
harder it will be for the late-comers to find and engage a reputable
solution provider to meet all of their needs in a timely manner.
3600 series of tablet press instrumentation, pharmaceutical
scientists were forced to develop in-house systems using the
technology available to them. That led to many non-standard
approaches, some quite good but many not so much and all of
them took time away from the principal objective that the scientist was trained for - formulation development.
INTERPHEX: Can you describe three aspects that have allowed your company to succeed?
GARY BUBB (SMI): First and foremost, always tell the customer what you promise to do, then do it. It is always better
to offer less and do more. All proposals must be good for the
client, SMI, and finally for humanity. SMI needs to charge a
fair price so that the product can be supported to the level expected by the client. The product must be useful with features
that actually assist the client to improve their product.
INTERPHEX: What is your company’s biggest success thus far?
GARY BUBB (SMI): Our reputation! SMI has a reputation
for the most advanced engineering in transducer design and
software, making a product that is user-friendly and beneficial.
INTERPHEX: What is the biggest challenge in your industry?
GARY BUBB (SMI): Making people realize that quality and
support has value. Price alone often results in a poor buying
INTERPHEX: Where do you see the industry going in the
next 10 years?
GARY BUBB (SMI): Machines that are easier to set up and
run unattended with minimal operator interaction.
INTERPHEX: What would you consider to be a major
achievement for the industry in the coming years?
GARY BUBB (SMI): A common operator in a control room
monitoring the operation of many machines at once, not just
tablet presses, but all processing machines.
INTERPHEX: What advice would you give to a professional
starting out in the industry that you wish you would have known?
GARY BUBB (SMI): Deliver an honest product at a fair
price with features that actually are beneficial to the client.
INTERPHEX: What don't most people realize about SMI?
GARY BUBB (SMI): The entire range of products that SMI
offers. It is always disappointing to learn that a potential client
was unaware of a service or product offered by SMI.
INTERPHEX: What are you looking forward to at
INTERPHEX this year?
GARY BUBB (SMI): Meeting with our clients, continue
building our relationships and making new friends.